Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Breast Cancer Res. 2011 Jul 26;13(4):R74.
Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J.
INTRODUCTION: Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D 25(OH)D concentrations on overall survival and distant disease-free survival.
METHODS: We conducted a prospective cohort study in Germany including 1,295 incident postmenopausal breast cancer patients aged 50-74 years. Patients were diagnosed between 2002 and 2005 and median follow-up was 5.8 years. Cox proportional hazards models were stratified by age at diagnosis and season of blood collection and adjusted for other prognostic factors. Fractional polynomials were used to assess the true dose-response relation for 25(OH)D.
RESULTS: Lower concentrations of 25(OH)D were linearly associated with higher risk of death (hazard ratio (HR) = 1.08 per 10 nmol/L decrement; 95% confidence interval (CI), 1.00 to 1.17) and significantly higher risk of distant recurrence (HR = 1.14 per 10 nmol/L decrement; 95%CI, 1.05 to 1.24). Compared with the highest tertile (55 nmol/L), patients within the lowest tertile (35 nmol/L) of 25(OH)D had a HR for overall survival of 1.55 (95%CI, 1.00 to 2.39) and a HR for distant disease-free survival of 2.09 (95%CI, 1.29 to 3.41). In addition, the association with overall survival was found to be statistically significant only for 25(OH)D levels of blood samples collected before start of chemotherapy but not for that of samples taken after start of chemotherapy (P for interaction = 0.06).
CONCLUSIONS: In conclusion, lower serum 25(OH)D concentrations may be associated with poorer overall survival and distant disease-free survival in postmenopausal breast cancer patients.
- - - - - - - - - - - -
- All items in Breast Cancer and Vitamin D
- UV decreased breast cancer risk by up to 2X – June 2011
- Cloudiness and Breast Cancer PDF file
- Need lots of UV AND vitamin D to reduce risk of breast cancer – Jan 2011
- Breast cancer reduced by 45 percent for women with the most vitamin D – July 2010
- The abstract fails to mention what the level of vitamin D was
- China has documented that less UV results in more cancer – June 2010
- esophagus, stomach, colon and rectum, liver, lung, breast, and bladder
- Breast Cancer vs latitude Gapminder
- Great U shaped curve
- No reduction in Breast Cancer when vitamin D less than 40 ng - May 2011
- All items in UV and vitamin D
- Breast Cancer recurred more when less than 20 ng of vitamin D – Oct 2010
- Breast cancer may result from poor interaction with vitamin D – Sept 2010 CYP27B1 and CYP24A1
- Women with breast cancer safely take 10,000 IU daily – Jan 2010